DemeRx, Inc.
Pharmaceutical company · Fort Lauderdale, Florida, United States
DemeRx, Inc. is a pharmaceutical company headquartered in Fort Lauderdale, Florida, United States. Its earliest recorded incorporation is in 2010. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $914,324 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $289,569 sold in a notice filed in 2015.
DemeRx at a glance
What does DemeRx do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $914,324 in total (2025). NIH funding came from the National Institute on Alcohol Abuse and Alcoholism.
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $289,569 sold (2015).
Frequently asked questions about DemeRx
Where is DemeRx headquartered?
DemeRx, Inc. is headquartered in Fort Lauderdale, Florida, United States.
What does DemeRx do?
DemeRx, Inc. is a pharmaceutical company.
When was DemeRx founded?
The earliest incorporation on record for DemeRx, Inc. is in 2010, according to public company registers.
Similar companies
- Alaunos Therapeutics, Inc.Fort Lauderdale, Florida, United States
- Sunshine Biopharma Inc.Fort Lauderdale, Florida, United States
- Cardinal Health 414, LLCFort Lauderdale, Florida, United States
- Kaya Holdings, Inc.Fort Lauderdale, Florida, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences